Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection

Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks

Liver International ◽

10.1111/j.1478-3231.2008.01859.x ◽

2009 ◽

Vol 29 (2) ◽

pp. 237-241 ◽

Cited By ~ 12

Author(s):

Maribel Rodriguez-Torres ◽

Sugantha Govindarajan ◽

Moises Diago ◽

Thomas Morgan ◽

Bhupinderjit Anand ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Hepatic Steatosis ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Viral Response ◽

Genotype 2 ◽

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2012.01586.x ◽

2012 ◽

Vol 19 (9) ◽

pp. 623-634 ◽

Cited By ~ 8

Author(s):

S. Pianko ◽

S. Zeuzem ◽

W.-L. Chuang ◽

G. R. Foster ◽

S. K. Sarin ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 2 ◽

A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan

Hepatology International ◽

10.1007/s12072-009-9134-1 ◽

2009 ◽

Vol 3 (3) ◽

pp. 468-479 ◽

Cited By ~ 10

Author(s):

Yoshiaki Iwasaki ◽

Yasushi Shiratori ◽

Shuhei Hige ◽

Shuhei Nishiguchi ◽

Hitoshi Takagi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Viral Load ◽

Hepatitis C ◽

National Study ◽

Genotype 1 ◽

Virus Genotype ◽

Genotype 2 ◽

Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2010.01303.x ◽

2010 ◽

Vol 18 (4) ◽

pp. 245-251 ◽

Cited By ~ 21

Author(s):

C. Pedersen ◽

Å. Alsiö ◽

M. Lagging ◽

N. Langeland ◽

M. Färkkilä ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Plasma Concentration ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Virus Genotype ◽

Genotype 2 ◽

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

Scandinavian Journal of Gastroenterology ◽

10.3109/00365521.2013.793389 ◽

2013 ◽

Vol 48 (7) ◽

pp. 839-847 ◽

Cited By ~ 10

Author(s):

Martin Lagging ◽

Karolina Rembeck ◽

Mads Rauning Buhl ◽

Peer Christensen ◽

Olav Dalgard ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 2 ◽

New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection

Journal of Medical Virology ◽

10.1002/jmv.23626 ◽

2013 ◽

Vol 85 (9) ◽

pp. 1523-1533 ◽

Cited By ~ 9

Author(s):

Hiroshi Abe ◽

Yuta Aida ◽

Haruya Ishiguro ◽

Kai Yoshizawa ◽

Nobuyoshi Seki ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 2 ◽

A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients and Those Without Treatment Options with Chronic Hepatitis C Virus Genotype 2 Infection

Value in Health ◽

10.1016/j.jval.2013.08.113 ◽

2013 ◽

Vol 16 (7) ◽

pp. A341

Author(s):

Z.M. Younossi ◽

S. Gordon ◽

S. Saab ◽

A. Ahmed ◽

S. Cure ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Markov Model ◽

Health Outcomes ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Virus Genotype ◽

Genotype 2 ◽

Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection

Hepatology ◽

10.1002/hep.22679 ◽

2008 ◽

Vol 49 (2) ◽

pp. 358-363 ◽

Cited By ~ 57

Author(s):

Alessandra Mangia ◽

Nicola Minerva ◽

Donato Bacca ◽

Raffaele Cozzolongo ◽

Ernesto Agostinacchio ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Chronic Hepatitis C ◽

Treatment Efficacy ◽

Virus Genotype ◽

Genotype 2 ◽

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3

Gastroenterology ◽

10.1053/j.gastro.2010.06.062 ◽

2010 ◽

Vol 139 (4) ◽

pp. 1267-1276.e4 ◽

Cited By ~ 59

Author(s):

David R. Nelson ◽

Yves Benhamou ◽

Wan–Long Chuang ◽

Eric J. Lawitz ◽

Maribel Rodriguez–Torres ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Α ◽

Virus Genotype ◽

Genotype 2 ◽

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study

BMC Infectious Diseases ◽

10.1186/s12879-017-2444-3 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 1

Author(s):

Edward J. Gane ◽

Edwin DeJesus ◽

Ewa Janczewska ◽

Jacob George ◽

Moises Diago ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Open Label ◽